In connection with the problem of the possible role played by the sympathomimetic neurohormones (nor-epinephrine and epinephrine) in the pathogenesis of essential hypertension, interest has been focused lately on substances which are capable of abnormally intensifying the vasoconstrictor power of epinephrine in the mesentery of the rat and the perfused rabbit's ear, such as the chemically undefined agent "VEM" which originates in the kidney (1) and protein fractions, extracted from the kidneys and other tissues, as well as hypertensin and tyrosin (2).
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A participation of adrenal cortical steroids in such "sensitizing" mechanisms is suggested by the restoration of the impaired VEM formation in the kidneys of adrenalectomized animals (3, 4) and by the enhancement of the vasoconstrictor effect of epinephrine on the perfused rabbit's ear, by addition of adreno-cortical extracts (5) .
In the intact dog and cat, subthreshold doses of epinephrine showed pressor activity after pretreatment with adrenal cortical hormones (6) , and in normotensive human subjects the pressor effect of subcutaneously injected epinephrine proved markedly intensified after several days of pretreatment with daily doses of 10 to 50 mg. of desoxycorticosterone acetate (7, 8) . On the other hand, the blood pressure effect of epinephrine has been reported as being weakened in patients with hypoadrenocorticism (9) (10) (11) .
The phenomenon of enhancement of the pressor action of epinephrine by desoxycorticosterone does not develop immediately after administration of the latter but seems to require a certain interval of latency, as indicated by its absence in the case of simultaneous intravenous injection of desoxycorticosterone glucoside and epinephrine (12, 13) .
1This study was aided in part by a grant from the National Heart Institute.
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In view of the fact that the earlier experiments in desoxycorticosterone acetate-pretreated human subjects (7, 8) had been carried out by use of the subcutaneous route of epinephrine administration, and considering the possibility that the finding of an increased pressor effect of epinephrine after desoxycorticosterone acetate might have been misleading due to an altered speed of subcutaneous absorption of the injected epinephrine, the following experiments with intravenous infusions of epinephrine were planned in order to obtain more conclusive results by avoiding that source of error.
Furthermore, we decided to carry out analogous experiments also with equal doses of nor-epinephrine, because this substance is assuming steadily increasing significance as an adrenal medullary hormone (14) (15) (16) , as the physiological chemical neurotransmitter of the sympathetic nervous system (17) and as a pressor agent whose hemodynamic effects are much more similar to the hemodynamic peculiarities of patients with essential hypertension than those produced by epinephrine. Nor-epinephrine elevates both the systolic and diastolic pressure through general vasoconstriction and does not produce cardiac acceleration in contrast to the prevailingly heartstimulating and accelerating effect of epinephrine, which functions largely as a vasodilator and produces its pressor action mainly by augmenting the cardiac output, leaving the diastolic pressure more or less unchanged or even lowering it (14, (18) (19) (20) (three of them borderline hypertensives), were subjected to the following tests before, and again at the conclusion of periods of seven to 22 (average 17) days on which they received daily injections of 10 mg. of desoxycorticosterone acetate (Percorten)4 intramuscularly: (1) Resting blood pressure level (auscultatory method; same observer); (2) Roentgenographic diameter of the heart; (3) Serum sodium and potassium (flame photometer); (4) Pressor effects of intravenous infusions of epinephrine and 1-norepinephrine (1-arterenol) 5 were tested in the following manner: A 19 gauge needle was inserted in the left cubital vein of the recumbent patient. The needle was connected with two three-way stopcocks, attached to each other and connected with three suspended 250 cc. infusion bottles. One of these bottles contained plain saline solution, the two others contained freshly prepared solutions of epinephrine and nor-epinephrine respectively. These solutions were made by adding 1 cc. of 1:1,000 epinephrine and l-nor-epinephrine respectively to each of two 250 cc. saline bottles. Each bottle was equipped with a "Venopak" venoclysis unit, the outflow from which was calibrated by counting the drops necessary to fill a 10 cc. space in a test tube. The figure thus obtained was multiplied with the weight of the patient in kilograms and divided by 400 to determine the number of drops required for the dose of 0. 
RESULTS
By comparing the findings before and after the period of desoxycorticosterone administration the following results were obtained:
(1) Resting blood pressure level. The average systolic and diastolic blood pressure levels remained practically unchanged in group A (eight patients with a normal salt intake), while there was a slight average increase in group B (seven patients receiving a daily extra dose of 10 grams of salt) ( Table I) .
(2) Heart size. The diameter of the heart was increased in six out of seven cases of group A (+ 5 to + 11 mm., average + 6 mm.) and in five cases of group B (+ 2 to + 17 mm., average + 8 mm.) ( Table I ). The roentgenographic findings in three cases had to be discarded because of differences in the position of the diaphragms.
(3) Serum electrolytes. The average sodium level remained practically unchanged in groups A and B (140 meq before, 141 meq after desoxycorticosterone acetate in both groups). The average potassium was diminished in all cases (average from 4.6 meq to 3.6 meq in group A; from 4.4 meq to 3.7 meq in group B).
(4) Pressor effect of epinephrine before and after desoxycorticosterone acetate. The blood pressure reactions to infusions of epinephrine are represented in Table I by the averages of the deviations of five successive readings (taken during each five minute infusion at one minute intervals) from the respective pre-infusion levels (see also Figure 2 ).
The average elevation of the systolic blood pressure due to epinephrine increased with increasing doses from + 6 to + 27 mm. The dias- -3/-9 -4/-10 -2/-4
Averages of the deviations of the lowest blood pressure levels reached within five minutes after the infusions from the respective pre-infusion levels.
ute of epinephrine was transformed into a slight elevation and all systolic and diastolic pressor responses became intensified, again progressing with increasing dosage (for tests of significance, see Table II ). There was practically no difference between the responses of groups A and B. The average post-infusion behavior of the systolic and diastolic pressure after treatment with desoxycorticosterone acetate was not significantly altered.
(5) Pressor effect of l-nor-epinephrine before and after desoxycorticosterone acetate. The effects of nor-epinephrine infusions on the systolic blood pressure were almost identical with those of equal doses of epinephrine (Table I, Figures  1 and 2) , whereas the diastolic pressure became elevated without exception and in a much greater degree than by epinephrine.
The post-infusion reaction within the first five minutes consisted essentially of a return to normal and there was no depression of the average diastolic pressure comparable to that produced by epinephrine (Table II, Figure 1) .
After desoxycorticosterone acetate the systolic pressor effect of nor-epinephrine was intensified in about the same manner as the systolic pressor effect of epinephrine. The diastolic pressor effect was also augmented in a similar degree as the diastolic pressor effect of epinephrine but on a higher level, in keeping with the greater elevation of the diastolic pressure, caused by nor-epinephrine per se (for tests of significance see Table II ).
There were no appreciable differences in the reactions of groups A and B.
The post-infusion reactions after desoxycorticosterone pre-treatment did not significantly differ from those elicited before administration of desoxycorticosterone acetate.
The electrocardiographic results will be presented separately.
COMMENT (A) Effects of epinephrine and nor-epinephrine per se. Various features, noticed during the intravenous infusion of epinephrine and norepinephrine, were in agreement with observations made previously by other investigators with similar techniques; for instance, the depression of the diastolic blood pressure by infusion of small doses of epinephrine (21, 22) ; the generally greater systolic pressor effect of epinephrine, compared with its diastolic effect (22); by contrast, the approximately equal systolic and diastolic pressor action and the bradycardia-producing effect of nor-epinephrine (18) (19) (20) ; the almost complete absence of subjective sensations during the infusion of nor-epinephrine, regardless of the degree of blood pressure elevation (18, 19) .
(B) Effects of desoxycorticosterone acetate per se. Larger doses and a more prolonged medication had been purposely avoided in order not to create significantly different basal blood pressure levels for the epinephrine and nor-epinephrine (14) 9.0043.55 (7) Nor-epinephrine (9) -The results are expressed as the mean increase of pressor response to epinephrine or nor-epinephrine at the indicated dose plus/minus the standard error; the numbers in parentheses indicate the number of subjects in each group. All six systolic response groups were "highly significant" (P in Fisher's 1-test for significance <0.01); two of the six diastolic response groups were also "highly significant"; three diastolic groups were "significant" (P 0.01 -0.05) and one group, namely, that for 0.1 -y/kg./min. nor-epinephrine, was "not significant" (P -0.5).
tests before and after treatment with desoxycorticosterone acetate.
The enlargements of the hearts of normotensive subjects, as seen in this series (in groups A and B alike) under the influence of desoxycorticosterone acetate, were only of a small degree but may not have been entirely insignificant in view of their uniformity and of the existence of similar, more striking observations, recorded in the literature (7, 23) .
(C) Effects of epinephrine and nor-epinephrine after pretreatment uith desoxycorticosterone acetate. The intensified pressor effect of intravenously infused epinephrine in desoxycorticosterone acetate-pretreated patients proves that similar results, obtained previously by use of the subcutaneous route (7, 8) , cannot be attributed to differences of epinephrine absorption from the subcutaneous tissue.
It also seems most unlikely that the intensification of the pressor effects of the sympathomimetic amines should have been caused by a retention of water and increase of the circulatory volume. Neither in group A nor in group B was there a significant increase in average body weight and earlier observations by others (24, 25) militate against a major significance of water retention in the mechanism of desoxycorticosterone-induced cardiovascular alterations.
The fact that desoxycorticosterone acetate intensified the pressor effect of nor-epinephrine as well seems of particular interest concerning the problem of essential hypertension in view of the possible pathogenic role of the sympathetic neurosecretion of nor-epinephrine into the vascular contractile effector cells and of an enhancement of its local constrictive efficiency under adrenal cortical influence (26) . It is true that desoxycorticosterone proper seems to be present in the adrenal cortex in only small amounts (27) but on the grounds of extensive experimental and clinical observations it is generally regarded as an acceptable function representative of the naturally occurring "mineralo-corticoids."
According to a recent report, the pressor effect of epinephrine in rats was only slightly and irregularly increased after pretreatment with desoxycorticosterone acetate (28) . This is to be explained in all likelihood by that fact that these animals had been made hypertensive by desoxycorticosterone acetate in contrast to our human subjects whose blood pressure remained practically unchanged and that consequently the basis for comparison was a different one. The frequent absence of an increased pressor effect of epinephrine also in hypertensive humans has been repeatedly observed (18, 21, 22, 29) . As a working hypothesis, the desoxycorticosterone-induced hypertension itself may be regarded as the result of a potentiation of the pressor efficiency of the intrinsic neurogenic norepinephrine deposits within the vascular muscle cells through desoxycorticosterone action. Studies concerning this point and the part played by the sodium ion in the mechanism of vascular pressor responsiveness are in progress.
While several investigators have reported a distinct accentuation of the blood pressure-elevating effect of desoxycorticosterone through the simultaneous intake of excessive amounts of sodium chloride (8, (30) (31) (32) (33) , the quantity and duration of extra salt intake in our cases of group B was obviously not sufficient to produce this phenomenon in a significant measure.
SUMMARY
Graded intravenous infusions of 1-nor-epinephrine and of epinephrine (0.1 to 0.3 microgram per kilogram per minute) in 12 non-hypertensive and three borderline hypertensive males produced pressor effects of specifically different patterns.
Administration of desoxycorticosterone acetate (10 mg. daily over an average of 17 days) did not alter the average resting blood pressure level of eight subjects who were on a normal diet. That of seven others who received in addition 10 grams of sodium chloride per day during the desoxycorticosterone acetate medication, became slightly elevated.
The average pressor effects of both 1-norepinephrine and epinephrine (systolic and diastolic) were significantly intensified after desoxycorticosterone acetate, except for the diastolic response to the smallest dose of l-nor-epinephrine. Addition of extra salt to the diet did not appreciably influence these reactions.
The average level of serum sodium was unchanged at the end of desoxycorticosterone administration; the potassium level was diminished. The heart diameters became slightly enlarged.
The possibility was briefly discussed that a potentiation of sympathomimetic pressor effects (due to intrinsic neurogenic nor-epinephrine in the vascular contractile cells and to circulating epinephrine and nor-epinephrine) under the influence of an exaggerated adrenocortical activity may be a pathogenic factor in essential hypertension.
